Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Sodium-glucose transport proteins (SGLT2) inhibitors & Heart Failure / Congestive heart failure (CHF)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Sodium-glucose transport proteins (SGLT2) inhibitors reduce the risk of hospitalization for patients with Heart Failure / Congestive heart failure (CHF) and a reduced ejection fraction
Anker et al. 2021 N Engl J Med 385:1451-1461

…

Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Anker et al. 2021 N Engl J Med 385:1451-1461
SGLT2 inhibitors in pts with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
Zannad et al. 2020 Lancet 398: 819-829
Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review
Rao 2022 Adv Ther 39(2): 845-861
Review

7/1/2026